Toronto Dominion Bank
INZY

Toronto Dominion Bank’s Inozyme Pharma INZY Stock Holding History

Toronto Dominion Bank’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2
Closed – – 1601
2022
Q1 		$0 Hold
2
– – ﹤0.01% 1691
2021
Q4 		$0 Buy
+2
New +$17 ﹤0.01% 1744

Other funds holding INZY

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Toronto Dominion Bank's INZY Position: Q2 2022 in Review

Toronto Dominion Bank sold out of Inozyme Pharma (INZY) in Q2 2022, closing a stake of 2 shares.

Toronto Dominion Bank first reported a position in INZY in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 47 funds tracked by Wall St. Rank hold INZY as of Q2 2022.

  • Toronto Dominion Bank reported no remaining Inozyme Pharma position as of Q2 2022 after selling out during the quarter.
  • Toronto Dominion Bank sold 2 Inozyme Pharma shares in Q2 2022.
  • Toronto Dominion Bank first reported a position in Inozyme Pharma in Q4 2021 and held it in 2 quarters.
  • Toronto Dominion Bank's Inozyme Pharma position peaked at $0 in Q1 2022.
  • 47 funds tracked by Wall St. Rank held Inozyme Pharma as of Q2 2022.

Based on Toronto Dominion Bank's 13F filing for Q2 2022, filed 11 Aug 2022.